• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Eko Unveils Redesigned Smart Stethoscope and Stethoscope Attachment

by Fred Pennic 11/25/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Eko Unveils Redesigned Smart Stethoscope and Stethoscope Attachment

– Eko unveils the second generation of CORE products, which includes a smart stethoscope and a stethoscope attachment designed to make any existing stethoscope smarter.

– The technological advancements of the CORE include active noise cancellation, sleeker design, and powerful software to allow medical professionals to more effectively screen for heart disease.

– The CORE Digital Attachment ($199) and the fully assembled CORE Digital Stethoscope ($249) are available for pre-order now to healthcare providers to enable them to provide the best possible care to their patients. 

Eko, a digital health company with an AI-powered cardiac screening platform, today announced the second generation of its CORE product line. An evolution from Eko’s first-generation CORE, the new CORE features powerful amplification and active noise cancellation that enables doctors and nurses to hear heart and lung sounds with greater clarity and screen patients for heart disease, the number one cause of death in the U.S., more effectively.

CORE Digital Attachment and CORE Digital Stethoscope Features

Eko Unveils Redesigned Smart Stethoscope and Stethoscope Attachment

The stethoscope is one of the most heavily relied upon screening tools for all medical professionals, and with Eko’s AI software it now gives every user the ears of a trained cardiologist to better screen for heart disease, which remains the number one cause of death. With a sleeker design, unprecedented active noise cancellation, and forthcoming decision support algorithms, the second-generation CORE will elevate what clinicians already use in every physical exam and close gaps in care created in part by analog stethoscopes. Since releasing its first-generation CORE in 2015, clinicians at over 4,000 hospitals have used the device to enhance their practice.

“When heart and lung sounds are amplified in the screening of heart valve and pulmonary diseases, everything changes,” said Connor Landgraf, co-founder, and CEO of Eko. “Our mission at Eko continues to be to enable all healthcare professionals to provide the highest level of cardiac care through non-invasive, reliable products. The redesigned CORE puts the ears of a trained cardiologist in the hands of any doctor or nurse.”

Eko’s Software Features

– Eko’s software allows users to capture, analyze and share sound data:

– Save 15, 30, 60 or 120-second recordings with “one click” recording button

– View sound waveforms and phonocardiograms

– Eko’s screening algorithms*, currently FDA-pending will assist clinicians in analyzing heart sounds for pathologic murmurs and valvular heart diseases

Share recordings with colleagues for a second opinion or live stream cardiology-grade sounds with an Eko Enterprise plan, which powers reliable real-time connections between clinicians and patients, or between clinicians for second opinions

Pricing & Availability

The CORE Digital Attachment ($199) and the fully assembled CORE Digital Stethoscope ($249) are now available for pre-order now to healthcare providers to enable them to provide the best possible care to their patients. 

“The better we can hear and the better we can screen, the better we can care for our patients,” said Dr. Steve Pham, VP of clinical research at Eko and an emergency medicine physician. “The CORE, coupled with Eko’s software, helps convert the device already worn around the neck of 30 million clinicians around the world into a powerful cardiopulmonary screening tool.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, algorithms, Cardiac Monitoring, Cardiologist, clinical research, decision support, digital health, digital stethoscope, Eko Core, Eko Devices, FDA, Heart, heart disease, lung, Machine Learning

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |